Abstract:Spinal cord injury (SCI) is a devastating neurological disorder that damages motor, sensory, and autonomic pathways. Recent advances in stem cell therapy have allowed for the <i>in vitro</i> generation of motor neurons (MNs) showing electrophysiological and synaptic activity, expression of canonical MN biomarkers, and the ability to graft into spinal lesions. Clinical translation, especially the transplantation of MN precursors in spinal lesions, has thus far been elusive because of stem cell heterogeneity and protocol variability, as well as a hostile microenvironment such as inflammation and scarring, which yield inconsistent pre-clinical results without a consensus best-practice therapeutic strategy. Induced pluripotent stem cells (iPSCs) in particular have lower ethical and immunogenic concerns than other stem cells, which could make them more clinically applicable. In this review, we focus on the differentiation of iPSCs into neural precursors, MN progenitors, mature MNs, and MN subtype fates. Previous reviews have summarized MN development and differentiation, but an up-to-date summary of technological and experimental advances holding promise for bench-to-bedside translation, especially those targeting individual MN subtypes in SCI, is currently lacking. We discuss biological mechanisms of MN lineage, recent experimental protocols and techniques for MN differentiation from iPSCs, and transplantation of neural precursors and MN lineage cells in spinal cord lesions to restore motor function. We emphasize efficient, clinically safe, and personalized strategies for the application of MN and their subtypes as therapy in spinal lesions.

Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Stem Cells: Current Approach and Future Prospects in Spinal Cord Injury Repair

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Progression of induced pluripotent stem cells for spinal cord injury as cell transplantation therapies

Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury

Cell therapy for spinal cord injury using induced pluripotent stem cells

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition

Current status and prospects of regenerative medicine for spinal cord injury using human induced pluripotent stem cells: a review

Spinal cord tissue engineering using human primary neural progenitor cells and astrocytes

Induced Pluripotent Stem Cell Technology for Spinal Cord Injury: a Promising Alternative Therapy

Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells

A Narrative Review of Advances in Neural Precursor Cell Transplantation Therapies for Spinal Cord Injury

Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair

Current Status of Cell-Mediated Regenerative Therapies for Human Spinal Cord Injury

Cell Transplantation for Repair of the Spinal Cord and Prospects for Generating Region-Specific Exogenic Neuronal Cells

How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?

Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques

Tumourigenicity And Immunogenicity Of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts In Syngeneic Mouse Brain

Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives